# PhishDestroy threat dossier — semaglutide-research.vip ================================================================ Fetched: 2026-07-16 18:47:27 UTC Canonical: https://phishdestroy.io/domain/semaglutide-research.vip/ ## VERDICT ---------------------------------------------------------------- CRITICAL THREAT — DO NOT VISIT Composite threat score: 100/100 (PhishDestroy scoring — see methodology below) ## DETECTION EVIDENCE ---------------------------------------------------------------- VirusTotal: 2/91 security vendors flagged this domain Flagging vendors: alphaMountain.ai, Fortinet AlienVault OTX: 2 pulses (threat-intel feed mentions) Public blocklists: listed on 1 independent blocklist ## INFRASTRUCTURE ---------------------------------------------------------------- IP address: 188.114.97.3 (US, San Francisco) ASN: AS13335 Cloudflare, Inc. Hosting org: AS13335 Cloudflare, Inc. Registrar: NICENIC INTERNATIONAL GROUP CO., LIMITED !!! REGISTRAR INTEGRITY ALERT — NiceNIC !!! NiceNIC International: over 90% of its registered domains are associated with illegal content; documented systematic abuse-report non-response. Primary sources: https://phishdestroy.io/nicenic-real https://phishdestroy.io/nicenic-verdict Nameservers: courtney.ns.cloudflare.com, dax.ns.cloudflare.com Registered: 2026-07-06 Expires: 2027-07-06 Page title: Semaglutide online — buy research-grade semaglutide, 99% pure | Pepidyn HTTP response: 200 ## TLS CERTIFICATE ---------------------------------------------------------------- Issuer: Google Trust Services / WE1 Expires: 2026-10-04 Status: INVALID chain Fingerprint: a803a638c4a9efe03f1cb9590d0147ae90933f3f36a6cd995e0d99b5eaeb51c2 ## ABUSE-REPORT HISTORY (evidence of registrar non-response) ---------------------------------------------------------------- Status: pending notification queue. No abuse reports filed yet — this domain is waiting for the next cycle of our automated abuse-reporter. ## TIMELINE ---------------------------------------------------------------- Domain registered: 2026-07-06 (per WHOIS / CT — may reflect a renewal or transfer date, not first-ever registration) First detected: 2026-07-10 12:10:44 UTC (by PhishDestroy tracker) Last verified: 2026-07-16 20:20:44 UTC Current status: ACTIVE / observable ## EXTERNAL CORROBORATION (third-party evidence) ---------------------------------------------------------------- URLScan.io: https://urlscan.io/result/019f4b81-13f8-71bb-8d2e-009390317787/ Wayback Machine: https://web.archive.org/web/*/semaglutide-research.vip crt.sh CT logs: https://crt.sh/?q=%25.semaglutide-research.vip Google transparency: https://transparencyreport.google.com/safe-browsing/search?url=semaglutide-research.vip AlienVault OTX: https://otx.alienvault.com/indicator/domain/semaglutide-research.vip URLhaus: https://urlhaus.abuse.ch/host/semaglutide-research.vip/ ## ANALYST NARRATIVE ---------------------------------------------------------------- [Generated: 2026-07-10 12:16:13 UTC — narrative may predate facts above. Treat fields in TIMELINE / DETECTION EVIDENCE / INFRASTRUCTURE as authoritative if they differ from the prose below.] This domain is flagged as a high-risk phishing operation targeting individuals seeking information on diabetes treatments, specifically semaglutide-based medications. The site mimics legitimate medical research portals to harvest personal data, login credentials, or financial details under the guise of clinical surveys or prescription offers. Analysis indicates the domain is designed to exploit trust in healthcare research, potentially leading to identity theft or unauthorized access to sensitive health records. Infrastructure analysis reveals multiple red flags confirming its malicious nature. The domain was registered on July 06, 2026, through NICENIC INTERNATIONAL GROUP CO., LIMITED, a registrar frequently associated with fraudulent domains. It resolves to the IP address 188.114.97.3, and despite its recent creation date, it has already been flagged by 2 out of 95 security vendors on VirusTotal. The SSL certificate, issued by Google Trust Services, provides a false sense of security, as phishing sites commonly use valid certificates to appear legitimate. Additionally, the domain holds a Gridinsoft trust score of 0/100, further confirming its high-risk status. If you or someone you know has visited semaglutide-research.vip, immediate action is required to mitigate potential damage. First, cease all interaction with the site and do not enter any personal or financial information. If credentials were submitted, change passwords for all accounts, especially those related to healthcare, banking, or email services. Enable multi-factor authentication where available. Monitor financial statements and credit reports for unauthorized activity, as stolen data may be used for identity theft or fraudulent transactions. Report the domain to relevant cybersecurity organizations or consumer protection agencies to aid in takedown efforts. Users should also scan their devices for malware, as phishing sites may deploy malicious scripts or redirect to exploit kits. [Updates since narrative was generated:] - VirusTotal detections: now 2/91 (narrative was written when count was lower) ## EVIDENCE HASHES ---------------------------------------------------------------- Favicon MD5: 065e29ce8a42943f71a07b4dff48eb52 TLS cert SHA-256: a803a638c4a9efe03f1cb9590d0147ae90933f3f36a6cd995e0d99b5eaeb51c2 ## SCORING METHODOLOGY ---------------------------------------------------------------- Composite score is NOT derived from VirusTotal alone. PhishDestroy aggregates: - VirusTotal positive ratio - Public blocklist consensus (MetaMask, ScamSniffer, OpenPhish, PhishTank, URLhaus, CryptoFirewall, SEAL, Polkadot, Enkrypt, Phishunt, DiscordPhishing, PhishingDB) - Cloaking detection (HTTP 666 or rendering delta between bot and real visitor) - DNS-filter consensus (Quad9, CleanBrowsing, NextDNS, AdGuard, Cloudflare, etc.) - AlienVault OTX pulses + Cloudflare Radar + Google Safe Browsing - URLScan / URLQuery verdicts - Brand-impersonation heuristics (DOM analysis of forms, logos, wording) - Known phishing-kit fingerprinting (favicon hash, JS obfuscation signatures) - Wallet-drainer family classification (Angel, MS, Rainbow, Pink, Inferno, ...) - Free-TLS vs paid-cert ratio (throwaway infrastructure signal) - Registrar/hosting abuse history (this registrar's track record) - Human researcher sign-off (operator takedown team) A domain present in our database is ALREADY flagged. A low VT count by itself does NOT mean the domain is safe — new scam domains routinely show 0/95 VT for their first 7–30 days while actively draining wallets. Always cross-reference the composite score and the individual indicators above, not just VT. ## CORRECTIONS / APPEALS ---------------------------------------------------------------- Full HTML report: https://phishdestroy.io/domain/semaglutide-research.vip/ JSON API: https://api.destroy.tools/v1/check?domain=semaglutide-research.vip Appeal a flag: https://phishdestroy.io/appeals/ (responded to within 48 hours, FP rate <0.01%) Submit a report: https://t.me/PhishDestroy_bot About PhishDestroy: independent open-source threat-intelligence platform. Tracked: 179,491 domains (50,959 alive under monitoring, 128,532 confirmed takedowns/dead). Site: https://phishdestroy.io